cornifelin Inhibitors
Cornifelin inhibitors are chemical compounds that specifically target and inhibit the activity of cornifelin, a protein that plays a role in the process of epidermal differentiation. Cornifelin, also known as CNFN, is expressed primarily in the outermost layers of the skin, particularly within the cornified envelope of keratinocytes, where it contributes to the structural integrity of the skin barrier. The protein is involved in the final stages of keratinocyte differentiation, during which cells lose their nuclei and become flattened, creating the protective barrier that shields the body from environmental insults. Cornifelin's function is linked to its ability to interact with other proteins and lipids in the epidermis, forming a cohesive and resilient barrier that prevents water loss and protects against pathogens.
Inhibitors of cornifelin are designed to disrupt its activity, either by preventing its interaction with other structural proteins or by interfering with its role in the assembly of the cornified envelope. These inhibitors could act by binding to specific domains of the cornifelin protein, preventing its proper folding, or by blocking the pathways through which cornifelin contributes to epidermal differentiation. By inhibiting cornifelin, researchers can explore its precise role in skin biology and better understand the molecular mechanisms behind keratinocyte maturation and the formation of the skin's protective layer. Cornifelin inhibitors are valuable tools for studying the regulation of epidermal homeostasis, offering insights into the processes that govern skin barrier formation and the maintenance of its integrity under various conditions.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Tenofovir | 147127-20-6 | sc-204335 sc-204335A | 10 mg 50 mg | $157.00 $646.00 | 11 | |
Tenofovir is a nucleotide reverse transcriptase inhibitor (NRTI) that interferes with the replication of viral RNA, inhibiting the reverse transcriptase enzyme, a crucial step in the HIV life cycle. | ||||||
Acyclovir | 59277-89-3 | sc-202906 sc-202906A | 50 mg 500 mg | $150.00 $940.00 | 2 | |
Acyclovir is a guanosine analogue that disrupts the replication of herpesviruses by inhibiting the viral DNA polymerase, blocking the elongation of viral DNA chains. | ||||||
Oseltamivir | 196618-13-0 | sc-507283 | 100 g | $324.00 | ||
Oseltamivir is a neuraminidase inhibitor used against influenza viruses. It inhibits the release of newly formed virus particles from infected cells by inhibiting the neuraminidase enzyme. | ||||||
Ritonavir | 155213-67-5 | sc-208310 | 10 mg | $124.00 | 7 | |
Blocks the protease enzyme, blocking the cleavage of viral polyproteins into functional proteins and thus inhibiting viral replication. | ||||||
Isoniazid | 54-85-3 | sc-205722 sc-205722A sc-205722B | 5 g 50 g 100 g | $26.00 $101.00 $146.00 | ||
Isoniazid is an antitubercular agent that disrupts the synthesis of mycolic acids in the cell wall of Mycobacterium tuberculosis, leading to bacterial cell death. | ||||||
Tamoxifen | 10540-29-1 | sc-208414 | 2.5 g | $272.00 | 18 | |
Tamoxifen is a selective estrogen receptor modulator (SERM) that competes with estrogen for binding to estrogen receptors in breast tissue, thereby inhibiting estrogen-driven breast cancer growth. | ||||||
Imatinib | 152459-95-5 | sc-267106 sc-267106A sc-267106B | 10 mg 100 mg 1 g | $26.00 $119.00 $213.00 | 27 | |
Imatinib is a tyrosine kinase inhibitor that targets the BCR-ABL fusion protein in chronic myeloid leukemia (CML) cells, blocking aberrant signaling and inhibiting the proliferation of CML cells. | ||||||
Bortezomib | 179324-69-7 | sc-217785 sc-217785A | 2.5 mg 25 mg | $135.00 $1085.00 | 115 | |
Bortezomib is a proteasome inhibitor used in multiple myeloma therapy. It disrupts the proteasome complex, leading to the accumulation of misfolded proteins and apoptosis in cancer cells. | ||||||
Sorafenib | 284461-73-0 | sc-220125 sc-220125A sc-220125B | 5 mg 50 mg 500 mg | $57.00 $100.00 $250.00 | 129 | |
Sorafenib is a multi-kinase inhibitor that inhibits various signaling pathways involved in cancer growth, including RAF/MEK/ERK and VEGF, making it effective against several types of cancer. | ||||||
Omeprazole | 73590-58-6 | sc-202265 | 50 mg | $67.00 | 4 | |
Omeprazole is a proton pump inhibitor (PPI) that suppresses gastric acid secretion by irreversibly inhibiting the H+/K+ ATPase pump in parietal cells, reducing stomach acid production. | ||||||